Physician profile
Peter E Khoury
NPI 1174057970
$15,481.34
in general payments reported to CMS, 2019-2025
14 companies · $869 in 2025
The $869 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,350 · 2022: $534 · 2023: $11K · 2024: $1,803 · 2025: $869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $2,793 · Travel and Lodging: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $2,792.77 |
| Travel and Lodging | $804.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,282.06 | 2022-2023 | Synchromedii |
| Boston Scientific Corporation | $3,033.93 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $797.50 | 2023-2025 | Proclaim, Eterna |
| Vertos Medical, INC. | $294.65 | 2023-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $281.59 | 2022-2024 | Sprint Pns System |
| Globus Medical, INC. | $238.85 | 2025 | Senza |
| Nevro Corp. | $234.30 | 2022-2023 | Senza |
| Stryker Corporation | $72.35 | 2023 | Spinejack |
| Collegium Pharmaceutical, INC. | $70.43 | 2022-2024 | Xtampza |
| Pfizer INC. | $63.98 | 2023 | |
| Curonix LLC | $43.78 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $30.41 | 2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.91 | 2022 | |
| Acacia Pharma INC | $16.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Khoury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.